VANGUARD GROUP INC - 30 Jun 2025 SCHEDULE 13G/A Report for Bridgebio Pharma Inc Common Stock (BBIO)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: Bridgebio Pharma Inc Common Stock
Symbol: BBIO
Shares outstanding: 189,919,182 shares
Disclosed Ownership: 16,484,985 shares
Ownership: 8.7%
Form type: SCHEDULE 13G/A
Filing time: 29 Jul 2025, 11:20:32 UTC
Date of event: 30 Jun 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	8.7%	16,484,985	0	186,259	Ashley Grim	Head of Global Fund Administration